1 Min Read
Jan 10 (Reuters) - Sarepta Therapeutics Inc
* Sarepta Therapeutics enters into license agreement with nationwide children’s hospital for GALGT2 gene therapy program Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.